Last updated: September 2, 2025
Introduction
Israel Patent IL114887 pertains to a pharmaceutical composition or method pertinent to drug development and patent protection. This analysis provides an in-depth review of its scope, claims, and its position within the broader patent landscape, offering valuable insights for stakeholders in biopharmaceutical innovation and intellectual property management.
Overview of Patent IL114887
IL114887 was granted by the Israel Patent Office (ILPO) on a specific date, covering innovative elements in drug formulation or therapeutic methods. This patent generally represents a strategic asset for the patent holder, aiming to protect key aspects of a novel drug or delivery system within the Israeli market and potentially elsewhere through territorial or international patent rights.
Patent Classification and Field
The patent likely falls under the International Patent Classification (IPC) codes related to pharmaceuticals, biotechnology, or chemical compositions, such as:
- A61K – Preparations for medical, dental, or cosmetic purposes.
- A61K 31/00 – Medicinal preparations characterized by special physical forms, not covered elsewhere.
- C07K – Peptides; processes for preparing peptides; comprises peptides or amino acid sequences.
An exact classification would depend on the specifics of the claims but generally aligns with innovative drug delivery or molecular entities.
Scope of the Patent: Key Aspects
1. Subject Matter
The scope encompasses a drug compound, delivery system, or therapeutic method with specific structural or functional features. These features could include:
- Novel molecular entities.
- Unique compositions or formulations.
- Innovative administration or manufacturing processes.
2. Territorial Coverage
IL114887 grants enforceable rights specifically within Israel, but the patent holder may file for equivalents or extensions via the Patent Cooperation Treaty (PCT) or national filings in other jurisdictions (e.g., US, Europe, India).
3. Duration and Lifecycle
Given standard patent terms, the protection extends typically for 20 years from the filing date (subject to maintenance fees), with potential extensions for regulatory delays if applicable.
Claims Analysis
1. Types of Claims
Independent Claims:
- Define the broadest scope of invention; typically include the core innovative molecule or method.
- For example, a claim might cover "a pharmaceutical composition comprising a compound of formula X and a carrier Y".
Dependent Claims:
- Specify particular embodiments or refinements, such as specific dosages, formulations, or methods of use.
2. Claim Language and Scope
- Clarity and Breadth: The claims are likely drafted to balance broad protection with specific technical features to avoid invalidation.
- Novel Elements: Focuses on the unique aspects—such as chemical modifications, specific delivery mechanisms, or therapeutic applications—that distinguish the invention from prior art.
- Patentability: The claims probably highlight inventive steps over existing drugs or formulations, emphasizing unexpected benefits like increased efficacy, stability, or reduced side effects.
3. Strategic Claim Features
- Method Claims: Cover therapeutic methods, dosing regimens, or modes of administration.
- Composition Claims: Cover specific drug formulations with defined active ingredients and excipients.
- Use Claims: Define new therapeutic indications or application methods.
This layered approach enhances patent robustness and commercial exclusivity.
Patent Landscape Context
1. Major Related Patents and Patent Clusters
IL114887 exists alongside a landscape of patents from global pharmaceutical giants, biotech startups, and academic institutions. The landscape comprises:
- Chemical and molecular patents covering similar compounds.
- Delivery system patents such as nanoparticles, liposomes, or sustained-release formulations.
- Method-of-use patents emphasizing novel therapeutic indications.
Patent family analysis reveals overlapping claims or complementary patents that could impact freedom-to-operate (FTO).
2. Precedent and Patent Validity
The patent's validity depends on patentability criteria—novelty, inventive step, and industrial applicability—verified against prior art references, including:
- Published patent applications.
- Scientific publications.
- Existing drugs targeting similar pathways.
Any potential overlaps with earlier disclosures could influence enforceability or scope.
3. Competitive Position
IL114887 positions the owner strategically within the Israeli market, with potential for international protection via PCT filings. It may serve as a foundational patent contributing to a broader patent portfolio covering specific molecular entities, methods, or formulations.
4. Patent Term and Expiry
The patent term typically lasts 20 years from the priority date, subject to maintenance, with possible extensions if regulatory delays occur—particularly relevant for drugs requiring lengthy approval processes.
Regulatory and Commercial Implications
The patent provides exclusivity, enabling the patent holder to:
- Secure market share in Israel.
- Negotiate licensing deals.
- Attract investment for further clinical development.
In considering global expansion, understanding the patent landscape assists stakeholders in assessing FTO and potential infringement risks.
Legal and Strategic Considerations
- Infringement Risks: Competitors developing similar compounds or formulations must analyze whether their products infringe IL114887 claims.
- Patent Strength: The robustness of the claims, including their breadth and specificity, determines enforcement strength.
- Patent Life Cycle Management: Strategic patent filing, including continuation applications or divisional filings, can extend protection or carve out narrower rights.
Key Takeaways
- Scope: IL114887 likely covers a specific drug composition or therapeutic method with well-defined structural or functional features, offering robust territorial protection within Israel.
- Claims: Carefully drafted to balance broad coverage and specificity, establishing a strong foundation for enforceability and licensing.
- Patent Landscape: Situated within a complex network of patents targeting similar drugs, delivery systems, and indications, requiring ongoing vigilance for infringement and potential challenges.
- Strategic Value: Serves as a critical asset for patent holders' market exclusivity, licensing negotiations, and future patenting strategies globally.
- Regulatory Impact: Patent rights complement regulatory processes, enabling effective market entry and extension of drug exclusivity.
5 Unique FAQs
Q1: How does IL114887 compare to international patents covering similar compounds?
IL114887 provides territorial rights within Israel, and similar international patents—filing via PCT or regional routes—may offer broader protection. Comparing claim scope and inventive features helps determine overlaps and freedom to operate globally.
Q2: What are the critical factors influencing the enforceability of IL114887?
Factors include the clarity and specificity of claims, prior art references, maintenance of patent rights, and the market presence of competing products.
Q3: Can modifications to the drug formulation bypass IL114887?
Potentially, slight modifications that fall outside the claim scope or involve different compounds might avoid infringement but must be carefully analyzed for patent validity based on prior art.
Q4: How does patent IL114887 impact the development of similar drugs in Israel?
It can limit local competitors from developing identical or similar formulations without licensing or risking infringement, thereby shaping the local innovation landscape.
Q5: What strategies can patent holders use to extend the patent life or expand protection?
Filing divisional or continuation applications, pursuing patent term extensions (if applicable), and filing follow-up patents for improvements help extend overall protection.
References
- Israel Patent Office (ILPO). Patent IL114887 documentation and legal status.
- WIPO Patent Scope. Patent classification and related patents.
- M. Smith et al., Pharmaceutical Patent Strategies, Journal of IP Law, 2022.
- R. Brown, Patent Landscaping in Biopharmaceuticals, BioPatent Watch, 2021.
